Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compliance to Long Term Imatinib Therapy in Newly Diagnosed Patients With Chronic Myeloid Leukaemia.

NCT00632255 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00632255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compliance to Long Term Imatinib Therapy in Newly Diagnosed Patients With Chronic Myeloid Leukaemia.
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
May 31, 2009
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, newly diagnosed